Warfarin Study (IMAGE)
Caption
A new five-year study of nearly 1,600 patients finds that genetic testing can help determine the safest dose of the blood thinner warfarin, with fewer side effects, in patients undergoing joint replacement surgery.
Credit
Intermountain Medical Center
Usage Restrictions
None
License
Licensed content